Buscar
01/11/2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Brandao, M, Prisciandaro, E, Xenophontos, E, Mariolo, A, Sadeghi, AH, Filippi, AR, Levy, A, Bandura, A, Caramella, C, Dickhoff, C, de Margerie-Mellon, C, Faivre-Finn, C, Portik, D, Sanchez-Lorente, D, De Ruysscher, D, Smit, E, Gobbini, E, Fadel, E, Ruffini, E, Olmetto, E, Cortiula, F, Bahce, I, Houda, I, Opitz, I, Naidoo, J, Edwards, J, Remon, J, Benitez, JC, Trujillo, JC, Derks, J, Amrane, K, Hartemink, KJ, Stathopoulos, K, Hendriks, LEL, Iglesias, M, Occhipinti, M, Guckenberger, M, Levra, NG, Girard, N, Reguart, N, Mercier, O, Bironzo, P, Hofman, P, Petersen, RH, De Angelis, R, Abgral, R, Terrisse, S, Popat, S, Pierret, T, Blum, TG, Ricardi, U, Dionisi, V, Berghmans, T, Dingemans, AMC. Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group. LUNG CANCER. 2025; 209DOI:10.1016/j.lungcan.2025.108798. PMID:41108881. IF:4.400(Q1/2D).
01/12/2025
Beyond Contraception: Exploring Health Benefits of Short-Acting Reversible Contraceptives-A Narrative Review
Perello-Capo, J, Quílez-Conde, JC, Calaf-Alsina, J. Beyond Contraception: Exploring Health Benefits of Short-Acting Reversible Contraceptives-A Narrative Review. WOMENS HEALTH REPORTS. 2025; 6(1)DOI:10.1177/26884844251405066. PMID:. IF:(Q/D).
01/10/2025
Proficiency in Laparoscopic Training: online versus Onsite Suturing Courses
Argay, I, Schettini, G, Giorgi, M, Habib, N, Rovira, R, Wattiez, A, Amro, B, Varbiro, S, Centini, G. Proficiency in Laparoscopic Training: online versus Onsite Suturing Courses. JSLS-Journal of the Society of Laparoendoscopic Surgeons. 2025; 29(4)DOI:10.4293/JSLS.2025.00084. PMID:41438213. IF:1.800(Q2/5D).
30/04/2025
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
González-Guerrero, L, Castellet, H, Martinez, Clara, González, N, Guijarro, F, Lloveras, N, Pratcorona, M, Gich, I, Berenguer-Molins, P, Perera-Bel, J, Zamora, L, Mascaró, M, Sampol, A, Garcia-Guiñón, A, Vives, S, Tormo, M, Arnan, M, Villamor, N, Nomdedéu, JF. CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases. Diagnostic Pathology. 2025; 20(1)DOI:10.1186/s13000-025-01655-w. PMID:40307896. IF:2.300(Q2/5D).